Eagle Pharmaceuticals, Inc. (EGRX)

Eagle Pharmaceuticals Revenue

Eagle Pharmaceuticals had revenue of $257.55M in the twelve months ending June 30, 2023, down -5.38% year-over-year. Revenue in the quarter ending June 30, 2023 was $64.65M, a -12.80% decrease year-over-year. In the year 2022, Eagle Pharmaceuticals had annual revenue of $316.61M with 84.56% growth.

• Revenue (ttm): $257.55M
• Revenue Growth: -5.38%
• P/S Ratio: 0.23
• Revenue / Employee: $1,922,022
• Employees: 134
• Market Cap: 59.35M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2022	316.61M	145.06M	84.56%
Dec 31, 2021	171.55M	-16.26M	-8.66%
Dec 31, 2020	187.80M	-8.09M	-4.13%
Dec 31, 2019	195.89M	-17.42M	-8.17%
Dec 31, 2018	213.31M	-23.40M	-9.88%
Dec 31, 2017	236.71M	47.23M	24.92%
Dec 31, 2016	189.48M	123.26M	186.11%
Dec 31, 2015	66.23M	47.13M	246.76%
Sep 30, 2014	19.10M	5.42M	39.62%
Sep 30, 2013	13.68M	11.14M	438.76%
Sep 30, 2012	2.54M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.